-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
[Generic Name] Prucalopride Succinate Tablets
[Approval Number] National Drug Approval No. H20203309
【Specification】1 mg × 24 tablets
【Packaging】Dual-aluminum packaging
【Medical Insurance】National Medical Insurance Category B
Category:
Tags:
- Details
-
- Commodity name: Prucalopride Succinate Tablets
- Commodity ID: 1491915529806041088
<p> [Generic Name] Prucalopride Succinate Tablets </p> <p> [Approval Number] National Drug Approval No. H20203309 </p> <p> 【Specification】1 mg × 24 tablets </p> <p> 【Packaging】Dual-aluminum packaging </p> <p> 【Medical Insurance】National Medical Insurance Category B </p>
[Generic Name] Prucalopride Succinate Tablets
【Approval Number】National Drug Approval No. H20203309
【Specification】1 mg × 24 tablets
【Packaging】Dual-aluminum packaging
【Medical Insurance】National Medical Insurance Category B
Related
Ondansetron Hydrochloride Tablets
[Generic Name] Ondansetron Hydrochloride Tablets
[Approval Number] National Drug Approval No. H20234368
【Specification】8 mg × 10 tablets/box
【Packaging】Tablets
[Contact Number] 13473127004 (Special Medications: Zhang Xiaohui)
[Generic Name] Mecobalamin Injection
[Approval Number] National Drug Approval No. H20066715
【Specification】1 ml: 0.5 mg
【Packaging】Glass ampoules
【Dosage Form】Injection
Paracetamol Mannitol Injection
[Generic Name] Acetaminophen Mannitol Injection
[Approval Number] National Drug Approval No. H20223397
【Specification】100 ml: 1000 mg
【Dosage Form】Injection
[Generic Name] Bupropion Tablets
[Approval Number] National Drug Approval No. H20223407
【Specification】4 mg
【Dosage Form】Tablets
Sodium Lactate Ringer's Injection
[Generic Name] Sodium Lactate Ringer’s Injection
[Approval Number] National Drug Approval No. H20044961
【Specifications】500 ml, 1000 ml
【Packaging Materials】Glass bottles, polypropylene infusion bottles, polypropylene infusion bags, stand-up polypropylene infusion bags, and multilayer co-extruded film infusion bags.
【Dosage Form】Injection
[Generic Name] Peritoneal Dialysis Solution (Lactate–G1.5%) Peritoneal Dialysis Solution (Lactate–G2.5%) Peritoneal Dialysis Solution (Lactate–G4.25%)
[Approval Numbers] National Drug Approval No. H20193081, National Drug Approval No. H20193085, National Drug Approval No. H20193080
【Specifications】Contains 1.5% glucose (2000 ml/bag), contains 2.5% glucose (2000 ml/bag), contains 4.25% glucose (2000 ml/bag).
【Packaging】Three-layer co-extruded membrane infusion bag for peritoneal dialysis, including a dual-bag accessory system for peritoneal dialysis
【Dosage Form】Injection
[Generic Name] Argatroban Injection
[Approval Number] National Drug Approval No. H20233354
【Specification】2 ml: 10 mg
[Packaging] Intermediate borosilicate glass ampoules
【Dosage Form】Injection
Pentoxifylline Sustained-Release Tablets
[Generic Name] Pentoxifylline Sustained-Release Tablets
[Approval Number] National Drug Approval No. H20233310
【Specification】0.4 g × 10 tablets/box
【Packaging】Aluminum-plastic blister pack
【Dosage Form】Tablets
Inquiry
* If you have any comments or suggestions, please feel free to leave us a message. We will be happy to assist you and respond as soon as possible.
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
